Blood Transfusion Devices Market By Type (Blood Bags, Blood Administration Sets, Needles and Syringes, Blood Filter Devices, Blood Transfusion Pumps), By Material (PVC (Polyvinyl Chloride), Polyethylene, Polypropylene), By Application (Trauma & Emergency, Surgical Procedures, Anemia Treatment, Cancer Treatment), By End-User (Hospitals, Blood Banks, Clinics, Homecare), and By Region; Global Insights & Forecast (2023 ? 2030)

As per Intent Market Research, the Blood Transfusion Devices Market was valued at USD 3.2 billion in 2024-e and will surpass USD 5.1 billion by 2030; growing at a CAGR of 8.3% during 2025 - 2030.

The blood transfusion devices market is growing steadily, driven by the increasing demand for blood transfusions in healthcare settings, especially in trauma care, surgical procedures, anemia treatment, and cancer therapy. These devices, which include blood bags, blood administration sets, blood transfusion pumps, and blood filter devices, play a critical role in ensuring the safe and efficient delivery of blood and blood products to patients. The rising prevalence of diseases such as anemia and cancer, coupled with an aging global population, is significantly contributing to the growing need for blood transfusions.

Advancements in blood transfusion technology, including improved blood storage and transfusion equipment, are further supporting the market's growth. Additionally, the rising focus on patient safety and the increasing adoption of homecare solutions for blood transfusion are expected to create new opportunities in the market. With the continued development of innovative devices that enhance the efficiency, safety, and ease of blood transfusions, this market is positioned for continued expansion.

Blood Bags are Largest Owing to Essential Role in Blood Transfusion Procedures

Blood bags are the largest segment in the blood transfusion devices market, owing to their essential role in storing and transporting blood and blood products. Blood bags are critical for the safe collection, preservation, and delivery of blood during transfusion procedures. The increasing prevalence of diseases requiring blood transfusions, such as anemia and cancer, has driven the demand for blood bags globally. These bags are used extensively in hospitals, blood banks, and clinics for a wide range of applications, making them the most significant product type in the market.

The continued advancements in blood bag technology, including improved material durability and storage capabilities, further bolster their position as the largest product type. Innovations aimed at enhancing the safety and shelf-life of blood stored in these bags are also contributing to their dominance in the market.

PVC (Polyvinyl Chloride) is Largest Material Owing to Versatility and Cost-Effectiveness

PVC (Polyvinyl Chloride) is the largest material used in blood transfusion devices, particularly blood bags, owing to its versatility, cost-effectiveness, and proven safety in medical applications. PVC is widely used because it offers excellent flexibility, clarity, and compatibility with blood products, ensuring the safe storage and transportation of blood. Its low cost and ease of manufacturing also make it the preferred material for many blood transfusion devices.

The ability to store blood safely for extended periods and its widespread use in hospitals, blood banks, and clinics make PVC the material of choice in the blood transfusion devices market. Additionally, the ongoing improvements in PVC formulations to enhance its performance and safety continue to sustain its dominance in the market.

Trauma & Emergency is Largest Application Owing to Critical Need for Blood in Emergency Situations

Trauma & emergency is the largest application segment in the blood transfusion devices market, driven by the critical need for blood transfusions in emergency and trauma care situations. Blood transfusions are often required in cases of severe injury, bleeding, and accidents, where the timely delivery of blood products is essential for saving lives. The increasing number of road accidents, injuries, and natural disasters is significantly contributing to the demand for blood transfusions in trauma and emergency settings.

Additionally, the growing emphasis on rapid response times in trauma care, alongside advancements in emergency medical services, is further propelling the demand for blood transfusion devices in these situations. As the need for emergency blood transfusions continues to rise globally, trauma and emergency applications remain the largest and most vital segment in the market.

Hospitals are Largest End-User Owing to High Demand for Blood Transfusion in Critical Care

Hospitals are the largest end-users of blood transfusion devices, largely due to the high volume of blood transfusions conducted in critical care settings. Hospitals, especially those with trauma units, intensive care units (ICUs), and surgical departments, frequently use blood bags, administration sets, and other transfusion devices to treat patients in need of blood products. The increasing number of surgical procedures, trauma cases, and critical illnesses that require blood transfusions makes hospitals the primary end-user for these devices.

The growing prevalence of cancer, anemia, and other conditions that necessitate blood transfusions further fuels demand in hospital settings. As hospitals continue to adopt advanced technologies and protocols for blood transfusion safety and efficiency, they will remain the dominant end-user of blood transfusion devices in the market.

North America is Largest Region Owing to Advanced Healthcare Infrastructure and High Blood Transfusion Demand

North America is the largest region in the blood transfusion devices market, primarily due to its advanced healthcare infrastructure and the high demand for blood transfusions in hospitals and clinics. The United States, in particular, is a major contributor to the region's market share, driven by the widespread use of blood transfusions in critical care settings, trauma centers, and surgical procedures. The rising prevalence of chronic diseases, such as anemia and cancer, has further fueled the demand for blood transfusion devices in North America.

Additionally, North America's strong regulatory environment, high healthcare standards, and the ongoing development of innovative transfusion technologies ensure that the region remains the largest market for blood transfusion devices globally.

Leading Companies and Competitive Landscape

The blood transfusion devices market is competitive, with major players such as Fresenius Medical Care, Terumo Corporation, Baxter International, and B. Braun Melsungen AG leading the market. These companies offer a wide range of blood transfusion products, including blood bags, administration sets, blood filters, and transfusion pumps, catering to various healthcare settings such as hospitals, blood banks, and clinics.

The competitive landscape is marked by continuous innovation, with companies focusing on enhancing the safety, efficiency, and ease of blood transfusion devices. Partnerships, acquisitions, and product development strategies are common as companies strive to strengthen their market position. As demand for blood transfusion devices grows, especially in trauma and emergency care, the competition in the market is expected to intensify.

Recent Developments:

• In December 2024, Terumo Corporation launched a new blood transfusion pump. The device features enhanced accuracy and safety features for hospital settings.
• In November 2024, B. Braun Melsungen AG introduced a blood filtration system. This system aims to reduce the risk of transfusion-related complications.
• In October 2024, Haemonetics Corporation expanded its blood collection product range. The expansion is focused on increasing blood bank efficiency.
• In September 2024, Grifols S.A. unveiled a next-gen blood bag system. This new system aims to improve the storage and safety of donated blood.
• In August 2024, Fresenius Kabi AG rolled out a mobile blood transfusion device for homecare use. The device enhances patient safety and comfort during home-based transfusions.

List of Leading Companies:

• Terumo Corporation
• Baxter International
• B. Braun Melsungen AG
• Grifols S.A.
• Smiths Medical
• Fresenius Kabi AG
• Medtronic PLC
• Haemonetics Corporation
• Johnson & Johnson
• Abbott Laboratories
• Blood Transfusion Solutions Pvt. Ltd.
• Macopharma
• Nipro Corporation
• Sarstedt AG & Co.
• Zhejiang Hisun Pharmaceutical Co., Ltd.

Report Scope: